Evaluating the consequences of critically ill patients with pediatric cancer at Aliasghar Children's Hospital

Forugh Charmduzi1, Hamidreza Khoshnezhad Ebrahimi2, Shabahang Jafarnejad2

  • 1Department of Pediatrics, Aliasghar Children's Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Insights

Pediatric cancer patients admitted to the pediatric intensive care unit (PICU) face poor outcomes. Risk factors like malignancy type and organ failure significantly impact survival, especially in underdeveloped regions.

Area of Science:

  • Pediatric Oncology
  • Critical Care Medicine
  • Epidemiology

Background:

  • Pediatric cancer remains a significant cause of mortality in children despite advances in treatment.
  • Supportive care and chemotherapy have improved outcomes, but PICU admissions indicate severe illness.
  • Understanding risk factors for PICU outcomes is crucial for improving pediatric cancer care.

Purpose of the Study:

  • To assess the correlation between risk factors and outcomes in pediatric cancer patients admitted to the PICU.
  • To identify specific factors influencing mortality and morbidity in this vulnerable population.
  • To inform strategies for better management and prognosis in pediatric oncology critical care.

Main Methods:

  • Retrospective cohort study of 127 pediatric oncology patients admitted to the PICU (age 1 month to 17 years).
  • Extraction of demographic and clinical data including cancer type, BMI, admission details, and organ failure.
  • Analysis of factors associated with patient outcomes in the PICU.

Main Results:

  • Mortality rates were highest for children with heart problems (75%), CNS involvement (54.2%), and sepsis (42.9%).
  • Significant factors affecting PICU outcomes included malignancy type, disease status, admission reason, patient condition, length of stay, and organ failure extent.
  • Hematological malignancies were particularly associated with poor outcomes.

Conclusions:

  • Prognosis for pediatric cancer patients in the PICU is suboptimal, particularly in underdeveloped regions.
  • Malignancy type, disease status, admission circumstances, patient condition, length of stay, and organ failure are key determinants of outcomes.
  • Targeted interventions addressing these factors are needed to improve survival rates in pediatric oncology critical care.
Abstract

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.4K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863